Loading...
EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression
BACKGROUND: Emerging evidence reveals the vital role of enhancer of zeste homolog 2 (EZH2) in cancer chemoresistance. However, its function and molecular mechanisms in breast cancer chemoresistance remain largely unknown. METHODS: Gene expression was evaluated using quantitative real-time PCR (qRT-P...
Na minha lista:
| Udgivet i: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859472/ https://ncbi.nlm.nih.gov/pubmed/32009798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S214104 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|